• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管活性肠肽通过蛋白激酶A、细胞外信号调节激酶和磷脂酰肌醇-3激酶诱导LNCaP前列腺癌细胞系发生神经内分泌分化。

Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K.

作者信息

Gutiérrez-Cañas Irene, Juarranz María G, Collado Beatriz, Rodríguez-Henche Nieves, Chiloeches Antonio, Prieto Juan C, Carmena María J

机构信息

Unidad de Neuroendocrinología Molecular, Departamento de Bioquímica y Biología Molecular, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.

出版信息

Prostate. 2005 Apr 1;63(1):44-55. doi: 10.1002/pros.20173.

DOI:10.1002/pros.20173
PMID:15468165
Abstract

BACKGROUND

Neuroendocrine (NE) differentiation in prostate cancer has been correlated with unfavorable clinical outcome. The mechanisms by which prostate cancer acquires NE properties are poorly understood, but several signaling pathways have been proposed. We have previously observed that vasoactive intestinal peptide (VIP) stimulates cAMP production mainly through VPAC(1) receptor, inducing NE differentiation in LNCaP cells. The aim of this study was to analyze the mechanisms involved in this process.

METHODS

Reverse transcriptase (RT)-polymerase chain reaction (PCR), quantitative real-time RT-PCR, Western blotting, and immunocytochemistry were performed.

RESULTS

LNCaP cells produce VIP, as demonstrated by RT-PCR and immunocytochemistry. VIP induced NE differentiation of LNCaP cells at a time as short as 1 hr of treatment, and the same occurred with the expression and secretion of neuronal-specific enolase (NSE, a NE differentiation marker). These effects were faster than those exerted by serum-deprivation. VIP induced extracellular signal-regulated kinase 1 and 2 (ERK1/2) phosphorylation and NE differentiation by PKA-dependent and independent pathways, since the PKA inhibitor H89 partially blocked VIP-induced NE differentiation and did not affect ERK1/2 phosphorylation. mitogen-activated protein kinase kinase (MEK) and phosphoinositide 3-kinase (PI3K) appear to be also involved since the inhibitors PD98059 and wortmannin abolished ERK1/2 phosphorylation and decreased NE differentiation induced by VIP. Moreover, VIP activated Ras suggesting the involvement of a Ras-dependent pathway.

CONCLUSIONS

VIP behaves as autocrine/paracrine factor in LNCaP cells by inducing NE differentiation through PKA, ERK1/2, and PI3K.

摘要

背景

前列腺癌中的神经内分泌(NE)分化与不良临床结局相关。前列腺癌获得NE特性的机制尚不清楚,但已提出了几种信号通路。我们之前观察到血管活性肠肽(VIP)主要通过VPAC(1)受体刺激cAMP产生,诱导LNCaP细胞发生NE分化。本研究的目的是分析这一过程中涉及的机制。

方法

进行逆转录(RT)-聚合酶链反应(PCR)、定量实时RT-PCR、蛋白质印迹法和免疫细胞化学。

结果

RT-PCR和免疫细胞化学证明LNCaP细胞产生VIP。VIP在处理1小时时即诱导LNCaP细胞发生NE分化,神经元特异性烯醇化酶(NSE,一种NE分化标志物)的表达和分泌情况也是如此。这些效应比血清剥夺所产生的效应更快。VIP通过PKA依赖和非依赖途径诱导细胞外信号调节激酶1和2(ERK1/2)磷酸化以及NE分化,因为PKA抑制剂H89部分阻断了VIP诱导的NE分化且不影响ERK1/2磷酸化。丝裂原活化蛋白激酶激酶(MEK)和磷脂酰肌醇3激酶(PI3K)似乎也参与其中,因为抑制剂PD98059和渥曼青霉素消除了ERK1/2磷酸化并降低了VIP诱导的NE分化。此外,VIP激活了Ras,提示存在Ras依赖途径。

结论

VIP在LNCaP细胞中作为自分泌/旁分泌因子,通过PKA、ERK1/2和PI3K诱导NE分化。

相似文献

1
Vasoactive intestinal peptide induces neuroendocrine differentiation in the LNCaP prostate cancer cell line through PKA, ERK, and PI3K.血管活性肠肽通过蛋白激酶A、细胞外信号调节激酶和磷脂酰肌醇-3激酶诱导LNCaP前列腺癌细胞系发生神经内分泌分化。
Prostate. 2005 Apr 1;63(1):44-55. doi: 10.1002/pros.20173.
2
Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.血管活性肠肽通过蛋白激酶A依赖性细胞外信号调节激酶途径在前列腺癌LNCaP细胞中反式激活雄激素受体。
Mol Pharmacol. 2007 Jul;72(1):73-85. doi: 10.1124/mol.107.033894. Epub 2007 Apr 12.
3
Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone.血管活性肠肽在实验性前列腺癌中对HER2的反式激活作用:生长激素释放激素类似物的拮抗作用
Int J Oncol. 2007 Nov;31(5):1223-30.
4
Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.环磷酸腺苷信号传导作为体外侵袭性人黑色素瘤细胞中血管生成拟态的介质
Cancer Res. 2009 Feb 1;69(3):802-9. doi: 10.1158/0008-5472.CAN-08-2391. Epub 2009 Jan 27.
5
IGF-I and vasoactive intestinal peptide (VIP) regulate cAMP-response element-binding protein (CREB)-dependent transcription via the mitogen-activated protein kinase (MAPK) pathway in pituitary cells: requirement of Rap1.胰岛素样生长因子-I(IGF-I)和血管活性肠肽(VIP)通过垂体细胞中的丝裂原活化蛋白激酶(MAPK)途径调节环磷酸腺苷反应元件结合蛋白(CREB)依赖性转录:Rap1的需求。
J Mol Endocrinol. 2005 Jun;34(3):699-712. doi: 10.1677/jme.1.01703.
6
Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.肾上腺髓质素是一种由雄激素撤退诱导产生的自分泌/旁分泌因子,它能刺激LNCaP前列腺肿瘤细胞中的“神经内分泌表型”。
Oncogene. 2008 Jan 17;27(4):506-18. doi: 10.1038/sj.onc.1210656. Epub 2007 Jul 16.
7
Leuprorelin acetate affects ERK1/2 activity in prostate cancer cells.醋酸亮丙瑞林影响前列腺癌细胞中的ERK1/2活性。
Int J Oncol. 2006 Jul;29(1):237-47.
8
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.前列腺肿瘤细胞获得神经内分泌特征是可逆的:对前列腺癌进展的影响。
Cancer Res. 1999 Aug 1;59(15):3821-30.
9
Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cells.血管活性肠肽(VIP)可增加人乳腺癌细胞中血管内皮生长因子(VEGF)的表达和分泌。
Regul Pept. 2007 Dec 4;144(1-3):101-8. doi: 10.1016/j.regpep.2007.06.006. Epub 2007 Jun 28.
10
Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.生长激素释放激素拮抗剂和血管活性肠肽拮抗剂对LNCaP前列腺癌细胞中前列腺特异性抗原(PSA)基因表达及释放的调控
Prostate. 2001 Aug 1;48(3):188-99. doi: 10.1002/pros.1097.

引用本文的文献

1
Chronic diarrhea related to neuroblastoma: the important role of vasoactive intestinal peptide in tumor pathology and survival.与神经母细胞瘤相关的慢性腹泻:血管活性肠肽在肿瘤病理学和生存中的重要作用。
BMC Cancer. 2025 Mar 13;25(1):457. doi: 10.1186/s12885-025-13870-1.
2
Heparin Oligosaccharides as Vasoactive Intestinal Peptide Inhibitors via their Binding Process Characterization.肝素寡糖通过其结合过程的表征作为血管活性肠肽抑制剂。
Curr Protein Pept Sci. 2024;25(6):480-491. doi: 10.2174/0113892037287189240122110819.
3
Endocrine and paracrine characteristics of neuroendocrine prostate cancer.
神经内分泌前列腺癌的内分泌和旁分泌特征。
Front Endocrinol (Lausanne). 2022 Nov 11;13:1012005. doi: 10.3389/fendo.2022.1012005. eCollection 2022.
4
Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors.靶向 VIP 和 PACAP 受体信号:设计 PACAP 受体亚家族药物的新见解。
Int J Mol Sci. 2022 Jul 22;23(15):8069. doi: 10.3390/ijms23158069.
5
Signal Transduction by VIP and PACAP Receptors.血管活性肠肽和垂体腺苷酸环化酶激活肽受体介导的信号转导
Biomedicines. 2022 Feb 9;10(2):406. doi: 10.3390/biomedicines10020406.
6
Association of BRAF V600E mutations with vasoactive intestinal peptide syndrome in MYCN-amplified neuroblastoma.BRAF V600E 突变与 MYCN 扩增神经母细胞瘤中血管活性肠肽综合征的关联。
Pediatr Blood Cancer. 2021 Oct;68(10):e29265. doi: 10.1002/pbc.29265. Epub 2021 Jul 31.
7
The inhibitory effect of melatonin on human prostate cancer.褪黑素对人前列腺癌的抑制作用。
Cell Commun Signal. 2021 Mar 15;19(1):34. doi: 10.1186/s12964-021-00723-0.
8
Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression.前列腺癌进展中神经发育过程与治疗诱导的神经内分泌可塑性之间的分子和功能联系
Cancers (Basel). 2021 Feb 9;13(4):692. doi: 10.3390/cancers13040692.
9
Valproic Acid Addresses Neuroendocrine Differentiation of LNCaP Cells and Maintains Cell Survival.丙戊酸可诱导LNCaP细胞的神经内分泌分化并维持细胞存活。
Drug Des Devel Ther. 2019 Dec 18;13:4265-4274. doi: 10.2147/DDDT.S229930. eCollection 2019.
10
A Clinical Approach for the Use of VIP Axis in Inflammatory and Autoimmune Diseases.VIP 轴在炎症和自身免疫性疾病中的应用的临床方法。
Int J Mol Sci. 2019 Dec 20;21(1):65. doi: 10.3390/ijms21010065.